Similar Articles |
|
The Motley Fool January 25, 2005 Stephen D. Simpson |
Prognosis Good for Merck The pharmaceutical weathered a tough year but should ride out its Vioxx troubles. While strict value investors may be put off, risk-tolerant investors can buy these shares today. |
The Motley Fool April 5, 2005 Selena Maranjian |
Don't Be a Simple-Minded Investor One mistake that many beginning investors (and some seasoned investors, as well) make is to put too much stock in one or a few measures as they evaluate companies as possible investments. |
The Motley Fool November 14, 2005 Tim Beyers |
Guarantee Your Returns Learning to invest is easy. Learning to beat the market isn't. That's why, over the course of decades, some of the best money managers in the business have relied on dividends for help. |
The Motley Fool January 13, 2006 Nathan Parmelee |
High Yield Isn't Always High Risk Time to change your thinking about high-yielding stocks. Investors who assume all high-yielding stocks carry with them higher levels of risk are shutting themselves out of profitable investment opportunities. |
The Motley Fool September 19, 2005 Nathan Slaughter |
Better Total Returns There's an easy way to do better, and it doesn't involve taking on more risk. Understanding that yield is a major component of total return is easy enough; putting that knowledge to work in your portfolio is the real test. |
The Motley Fool April 26, 2004 Mathew Emmert |
Powerful Payouts Stock yields are still better than some might suggest. Have a look at why current dividend yields are anything but puny and what they can add to your bottom line. |
The Motley Fool September 2, 2005 Nathan Parmelee |
3 Stocks That Can Pay More Dividend growth is as important as the dividend itself. Here are three stocks that make the dividend growth cut. Polaris Industries... Nokia... Kimberly-Clark... |
The Motley Fool October 8, 2004 Whitney Tilson |
Blue-Chip Bargains? Sifting through beaten-down stocks may yield some good investments. But be careful, most of these stocks are that way for a reason. |
The Motley Fool December 21, 2006 Brian Lawler |
Dueling Fools: Merck Bull What you are getting with Merck is one of the best-managed pharmas out there that will be experiencing solid double-digit earnings growth in the not-too-distant future with a smart dividend payout. |
The Motley Fool January 13, 2005 Selena Maranjian |
Big Dividend Payers Big dividend payers can reward you well, but select carefully. |
The Motley Fool March 9, 2009 Brian Orelli |
Merck-Schering Trumps Pfizer-Wyeth The new Merck deal looks a lot better than a combined Pfizer plus Wyeth. |
The Motley Fool December 21, 2006 Ryan Fuhrmann |
Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space. |
The Motley Fool May 3, 2006 Selena Maranjian |
When Dividends Are Dicey A hefty dividend yield isn't always something investors can count on. |
The Motley Fool January 23, 2006 Selena Maranjian |
Money Making Money Put the snowball principle to work for your portfolio. But it is important to study dividend-paying candidates (and any stock you're considering, for that matter) carefully. |
The Motley Fool December 17, 2004 Tim Beyers |
Give the Gift of Cash No gift lifts sagging returns more than cold, hard moolah by way of dividends. Here's some underpriced stocks that give like Santa: New York Community Bank... Knightsbridge Tankers... BB&T... etc. |
The Motley Fool April 26, 2006 Tim Beyers |
Where the Yields Are The best dividend payers are perhaps not where you think. Great businesses that boast high yields can be found in any industry, as long as you broaden your search to overseas markets. |
The Motley Fool September 8, 2004 Tim Beyers |
What Is a Good Dividend? One expert tours the market to find out what makes a worthwhile dividend. |
The Motley Fool September 30, 2004 W. D. Crotty |
Merck Chokes Back Vioxx The $2.3 billion arthritis drug is withdrawn from the market after clinical studies point to dangerous side-effects. Despite the bad news, Merck's big dividend payouts don't appear to be in jeopardy at the moment. |
The Motley Fool September 27, 2004 Mathew Emmert |
How to Be a Dividend Investor Here are the tools you need to build a diverse portfolio of high-quality, dividend-paying investments. Read on to learn a few things about evaluating the power of the payout. |
The Motley Fool June 10, 2005 Selena Maranjian |
How Not to Value Stocks Don't confuse price tags with intrinsic value. A stock's price alone is much less meaningful than you may think. |
The Motley Fool April 26, 2005 Tim Hanson |
More Money, Less Risk In good times and bad, dividends deliver the best of the market. |
The Motley Fool June 5, 2006 Chuck Saletta |
Get Paid for Your Patience You can beat the market over time with a dividend-focused strategy. Such a strategy will also assure that you get paid while you wait for the market to realize just how valuable your companies truly are. |
The Motley Fool March 15, 2004 Bill Mann |
Don't Be a "Yield Pig" Is an 8% dividend yield better than a 4% yield? "Not necessarily," says Bill Mann. After the change in the tax treatment of dividends last year, investors suddenly started valuing dividend-paying companies slightly higher. |
The Motley Fool February 27, 2006 Tim Beyers |
The Agony of Dividend Defeat In the Olympics, it takes only one tiny slip. The same goes for your portfolio. Buy stock only in dividend payers that pass the test, and then routinely reinvest the proceeds. |
The Motley Fool November 22, 2005 Stephen D. Simpson |
Diving Into The Dow: The Fifth Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: McDonald's... Merck... Microsoft... Pfizer... Procter & Gamble... |
The Motley Fool August 22, 2005 Mathew Emmert |
Dividend Stocks Beat the Market Let dividends lead you to miraculous investment returns. |
The Motley Fool April 18, 2006 Seth Jayson |
Play the Right Numbers As an investor, you might be able to learn something from the bookies out there. Investing in solid dividend-paying companies beats the market with lower risk. |
The Motley Fool April 21, 2009 Brian Orelli |
Schering and Merck: A Match Made in Purgatory Until Merck can show that it's capable of growing sales again, investors should be leery of stepping in, even with the dividend yield pushing 6%. |
The Motley Fool December 21, 2006 Ryan Fuhrmann |
Dueling Fools: Merck Bear Rebuttal Yes, Merck is a good company, but investors can still do better. |
The Motley Fool May 19, 2005 Tim Hanson |
The Power of Free Money Hear that Drip? It's your portfolio growing. The best candidates for Drips (dividend reinvestment plans) are stocks that increase dividends regularly and appreciate in the market. |
The Motley Fool February 22, 2005 Charly Travers |
Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list. |
The Motley Fool March 1, 2004 Mathew Emmert |
How to Be an Income Investor Develop a high-quality, income-producing portfolio now. Provided are the tools you need to build a diverse portfolio of high-quality, income-producing investments. |
The Motley Fool November 25, 2011 Dan Caplinger |
Has Merck Become the Perfect Stock? Like most other pharma companies, Merck is dealing with the imminent loss of patent protection on one of its blockbuster drugs. |
The Motley Fool February 10, 2006 Tim Hanson |
Good Stocks to Buy Now Put the market to work for you -- today: Altria... Abbot Labs... Bristol-Myers... Tootsie Roll... Pfizer... Coca-Cola... Merck... |
The Motley Fool July 16, 2010 Eric Bleeker |
Buy, Sell, or Hold Frontier Communications? Should dividend-focused investors be looking to Frontier as an all-star candidate for their portfolio? Is a dividend of this size sustainable? To discern this, here's a list of reasons to buy, sell, or hold Frontier Communications. |
The Motley Fool January 6, 2006 Tim Hanson |
Hit the High-Yield Jackpot Are your dividends too good to be true? High-yield stocks are only worthwhile when investors receive the advertised return. |
The Motley Fool February 14, 2009 Ilan Moscovitz |
The Next 3 Dividend Dynamos A few stock ideas for this market. |
The Motley Fool August 25, 2004 Ben McClure |
Baby Bells' Silver Lining While these might be gloomy days for telecommunications stocks, it's too early to count Verizon, BellSouth, and SBC Communications out. |
The Motley Fool November 25, 2009 Jennifer Schonberger |
7 Dividend Divas Check out these income stocks for steady dividend returns: Alliance Resource Partners... Altria Group... AT&T... Bristol-Myers Squibb... Southern Company... Eli Lilly... Verizon... |
The Motley Fool February 15, 2006 Selena Maranjian |
We Buy What We See In investing, your selection is limited. Here are a few tips to help you find better investments. |
The Motley Fool May 11, 2005 Brian Richards |
What Every Portfolio Needs Want a strong core investment? Look no further than dividend-paying stocks. |
The Motley Fool April 3, 2006 Tim Hanson |
Stocks Worth Forgetting It's as simple as a fire drill: Buy, hold, and reinvest. These are exactly the kinds of stocks you can buy and forget about: Sysco... Bank of America... Pitney Bowes... etc. |
The Motley Fool December 23, 2005 Nathan Parmelee |
The Investing Strategy That Keeps Giving The best results from dividends require patience, a long-term time horizon, and excellent companies for your investment dollars. |
The Motley Fool January 31, 2007 Brian Lawler |
Merck Plays the Waiting Game New acquisitions may help the drugmaker weather tough times. Investors, take note. |
The Motley Fool May 31, 2005 Nathan Parmelee |
Following a Master Investor's Lead A look at how one leading investment mind crushed the market by focusing on dividends. John Neff's long-term record of success is ample proof that dividends are where it's at. |
The Motley Fool October 30, 2009 Dan Caplinger |
Should You Dump These Dividend Stocks? After the market's big rally, many stocks have seen their dividend yields drop sharply. Do those falling yields mean that you should get out of these dividend stocks now before it's too late? |
The Motley Fool August 22, 2005 Stephen D. Simpson |
Vioxx Brings the Pain A jury stings Merck for hefty Vioxx damages, battering shares. |
BusinessWeek December 22, 2003 Robert Barker |
A Stimulant For Depressed Drug Stocks? For a bunch of can't-miss stocks, the big drugmakers sure did miss out on 2003's bull run. The dozen drug companies in the Standard & Poor's 500-stock index have returned 10% this year, vs. the index' 22%. But the market is now failing to credit the companies' strengths. |
The Motley Fool June 8, 2009 Selena Maranjian |
Double Your Dividends in Six Years Here's how you can collect thousands of dollars annually (and easily). |
The Motley Fool August 13, 2010 Ilan Moscovitz |
Merck: Dividend Dynamo or Disaster? Just how safe is this dividend? |